Disclosures for "Replication-competent Adenovirus-mediated Double Suicide Gene Therapy With Fractionated Stereotactic Radiosurgery in Progressive Glioblastoma: A Phase One Trial"
-
Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion .
-
The institution of Dr. Lee has received research support from National Institute on Aging (NIA).
-
The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Premier Applied Sciences. The institution of Dr. Snyder has received research support from Vizilitics inc.
-
Ms. Shah has nothing to disclose.
-
Dr. Siddiqui has nothing to disclose.
-
Dr. Robin has nothing to disclose.
-
Prof. Brown has nothing to disclose.
-
Dr. Movsas has stock in abbvie. Dr. Movsas has stock in united therapeutics. Dr. Movsas has stock in biolife. Dr. Movsas has stock in acrivon. Dr. Movsas has stock in metlife. The institution of Dr. Movsas has received research support from Siemens. Dr. Movsas has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. Siddiqui has nothing to disclose.
-
Dr. Nyati has nothing to disclose.